Literature DB >> 21534133

Training in addiction medicine in Australia.

Paul S Haber1, Bridin P Murnion.   

Abstract

Barriers to entering addiction medicine (AM) have led to a persisting workforce shortage. To address this problem, the Chapter of Addiction Medicine (AChAM) was formed in 2001 as a subdivision of the Royal Australasian College of Physicians (RACP). Through consultation, AChAM has identified the scope of practice and offered fellowship to suitable established practitioners. The Chapter successfully applied to the Australian Government for recognition of AM as a medical specialty, which was finalized in November 2009. Specialist reimbursement item numbers were incorporated into that decision process and commence operating in November 2010. AChAM has designed and implemented a training scheme using a model similar to that of the RACP internal medicine training program. This comprises 3 years of basic general medical training post internship followed by 3 years of discipline-specific supervised training. The training is broadly based, with experience in both ambulatory care and inpatient care, and including physical health as well as mental health. Assessment is continuous and competency based. There is no exit examination. The overriding clinical approach rests upon the harm minimization framework consistent with long-established national drug policy in Australia and favors evidence-based treatment.

Mesh:

Year:  2011        PMID: 21534133     DOI: 10.1080/08897077.2011.555718

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  2 in total

1.  Two birds with one stone: experiences of combining clinical and research training in addiction medicine.

Authors:  J Klimas; R McNeil; K Ahamad; A Mead; L Rieb; W Cullen; E Wood; W Small
Journal:  BMC Med Educ       Date:  2017-01-23       Impact factor: 2.463

2.  Optimising treatment in opioid dependency in primary care: results from a national key stakeholder and expert focus group in Ireland.

Authors:  Marie Claire Van Hout; Des Crowley; Aoife McBride; Ide Delargy
Journal:  BMC Fam Pract       Date:  2018-06-30       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.